Scientists from the University of KwaZulu-Natal conducted a test trial on a group of women from Umlazi to determine the ...

Explore the top-performing Nasdaq 100 stocks this year as the index moves into a technical bear market this year.

On World AIDS Day 2024, UNAIDS proposed use of a human rights-based approach to end the HIV pandemic by 2030.1 Their approach is centred on achieving equity in access to HIV prevention and treatment, ...

The injection, known as Lenacapavir, works by preventing the virus from multiplying within body cells and could provide protection for an entire year. Researchers noted that the injection differs from ...

Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...

On the same day the Trump Administration unceremoniously shut down the U.S. Department of Health and Human Services Regional ...

PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...

The Trump administration’s cuts to a global AIDS relief program threaten to upend rollout of a groundbreaking HIV prevention ...

A groundbreaking Phase 1 study suggests that once-yearly intramuscular lenacapavir could be a promising option for HIV PrEP.

She’d acquired HIV as a college student in the 1980s, she told the audience at an infectious disease conference in San ...

News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top ...

Citigroup said it’s “very bullish” on Gilead’s HIV franchise, arguing it’s the drugmaker’s biggest value driver as the company’s new ...